GPO ramps up domestic antiviral production following shortage concerns
The Government Pharmaceutical Organization is expected to produce Favipiravir antiviral medication for COVID-19 treatment of more than 40 million tablets per month from October onwards, following concerns raised by hospitals on potential shortages. The Government Pharmaceutical Organization (GPO) has revealed its expected production yield of locally produced Favipiravir is 2.5 million tablets in August, 23 […]
Read More Read More





